HB 3409: Allows insurers offering policies or certificates of health insurance and pharmacy benefit managers to require that a claim for reimbursement of a prescription drug include a modifier or other indicator that the drug is a 340B drug unless certain requirements are met.
Public testimony analysis — 4 testimonies submitted
Testimony Sentiment
1
Support
3
Oppose
0
Neutral
Organizational Positions2 organizations
Individual Testimony by Location2 locations
| Location | Total | Support | Oppose |
|---|---|---|---|
| Johnson and Johnson | 1 | 0 | 1 |
| PhRMA | 1 | 0 | 1 |